行情

CTSO

CTSO

Cytosorbents
NASDAQ

实时行情|Nasdaq Last Sale

4.170
-0.080
-1.88%
盘后: 4.170 0 0.00% 16:00 11/15 EST
开盘
4.310
昨收
4.250
最高
4.310
最低
4.010
成交量
19.20万
成交额
--
52周最高
11.20
52周最低
3.680
市值
1.35亿
市盈率(TTM)
-6.4541
分时
5日
1月
3月
1年
5年

分析师评级

4位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

CTSO 新闻

  • 马斯克:NASA付给波音载人航天费用太高 这不公平
  • 新浪科技.5小时前
  • 波音737客机又出事!飞行途中出现故障 紧急迫降
  • 海外网.6小时前
  • 约500万美国人有睡眠问题 手机可能是罪魁祸首
  • 新华国际.6小时前
  • 世界首富易主!比尔·盖茨反超亚马逊CEO贝佐斯登顶
  • 中国新闻网.6小时前

更多

所属板块

先进医疗设备和技术
+2.55%
医疗设备和用品
+1.69%

热门股票

名称
价格
涨跌幅

CTSO 简况

CytoSorbents Corporation is a critical care focused immunotherapy company. The Company is engaged in commercializing its product, CytoSorb, which is a blood purification technology with focus in preventing or treating multiple organ failure. The Company's purification technologies are based on biocompatible, porous polymer beads that remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. The Company's CytoSorb is an extracorporeal cytokine filter and is designed to reduce the cytokine storm that causes inflammation, organ failure and death in common critical illnesses, such as sepsis, burn injury, trauma, lung injury and pancreatitis. In addition, CytoSorb is used in other inflammatory conditions, such as cardiac surgery and autoimmune disease flares and cancer cachexia. It also has other products under development based upon its blood purification technology, including HemoDefend, ContrastSorb, DrugSorb, BetaSorb and others.
展开

Webull提供Cytosorbents Corp的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。